Some of China Resources Shuanghe (600062.SH) drugs will be selected for centralized drug procurement nationwide

Zhitong Finance App News, China Resources Shuanghe (600062.SH) announced that on July 31, 2026, the company and some of its subsidiaries participated in the 12th batch of national centralized drug procurement bids organized by the Joint Procurement Office. The company plans to select some products, including amlodipine benazepril oral regular release dosage forms, for this centralized procurement.

This centralized drug procurement is the 12th batch of centralized procurement of national drugs. During the procurement cycle, medical institutions will give priority to using selected drugs from this centralized drug procurement and ensure that the agreed procurement volume is completed. The products to be selected this time will be selected, signed and implemented, which will help increase the product market share, enhance the company's brand influence, and have a positive impact on the company's future business performance.